Overview
This is an invitation for visionary biotech founders and startup teams. Our investment group is ready to allocate capital ranging from $250,000 to $5 million to innovative projects in the biotechnology sector. We prioritize companies that are developing transformative solutions in areas such as therapeutics, diagnostics, and medical devices. We look for teams that can articulate their market strategy and show a clear path to commercialization. We are particularly interested in startups based in Japan and the United States, aiming to bridge innovative ideas with strategic market needs.
Investor profile
Emiko Tanaka is an experienced investor focused on the biotechnology industry, with a keen eye for startups that show exceptional promise and innovative technology. Our capital style is participative, preferring to engage closely with the teams we fund and assist them in executing their vision.
Requirements
Founders should have a solid business plan, a prototype or proof of concept, and a team with relevant expertise in biotech. A clear understanding of the competitive landscape and regulatory path is essential.
Open investor offer
Open this investor offer to get access to investor contact details and continue communication with the investor.